SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Eva Perón

PatientEva Perón
Date of birth1994-05-07
IdentifiersMRN HR-ML025-SYN; SSN (made up) 000-25-7316
Document date2026-02-17
AuthorLucía Barragán, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Biopsy result, and gynecologic oncology consultation the same day. [S]

History of Present Illness

Ms. Perón returns eight days after her first visit, as arranged, to hear her biopsy result in person; the visit is in Spanish. Before giving the result, Dr. Barragán asked what she understood so far and how she wanted to hear news. She said she suspected something serious, wanted to know everything, directly and herself, and wanted no one else in the room. She was told plainly that the biopsy shows a cancer of the cervix, an invasive squamous cell carcinoma, and that the HPV test found HPV type 16 and the cytology also showed cancer cells. After a pause and some tears she asked whether it can be cured, whether she will be able to work, and whether she could have children. Dr. Osei-Bonsu of gynecologic oncology then joined, with a professional Spanish interpreter, as Ms. Perón agreed. Since the first visit the bleeding has been lighter, she takes the iron daily with dark stools and no stomach upset, and she uses acetaminophen once or twice a day for the pelvic ache. [S]

ElementDetail
Result givenInvasive squamous cell carcinoma of the cervix; HPV 16 positive; cytology with cancer cells
How it was givenIn person, in Spanish, to her alone, after asking what she wanted to know
Her questionsCure, work, and children
BleedingLighter; iron taken daily
ScoresPelvic pain 4 of 10; PHQ-9 9; GAD-7 9

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired; no fever or weight loss
GenitourinaryPositiveLighter bleeding; no urinary symptoms or blood in the urine
GastrointestinalNegativeDark stools on iron; no rectal bleeding or pain on opening the bowels
MusculoskeletalNegativeNo back or leg pain; no leg swelling
PsychiatricPositiveShocked and frightened by the news; no thoughts of self-harm

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth once daily, with vitamin C-rich food or juice, apart from tea and dairyOne tablet by mouth once dailyOral route2026-02-09 to 2026-08-17completedS
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours when needed for pelvic pain, no more than 6 tablets a dayOne or two tablets every 6 hours when needed, no more than 6 a dayOral route2026-02-09activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-02-17Body height165cmS
2026-02-17Body weight52.8kgS
2026-02-17Body mass index (BMI) [Ratio]19.4kg/m2S
2026-02-17Systolic blood pressure112mm[Hg]S
2026-02-17Diastolic blood pressure70mm[Hg]S
2026-02-17Heart rate90/minS
2026-02-17Respiratory rate16/minS
2026-02-17Body temperature36.7CelS
2026-02-17Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-17Creatinine [Mass/volume] in Serum or Plasma0.7mg/dL0.5-1.1 mg/dLNormalS
2026-02-17Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M117mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-02-17Pain severity - 0-10 verbal numeric rating [Score] - Reported4{score}S
2026-02-17Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
2026-02-17Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]9{score}S

Physical Exam

Vital signs recorded on 2026-02-17; see the Vital Signs section. [S]

SystemFinding
GeneralPale; pulse 90, blood pressure 112/70
AbdomenSoft; no mass; no enlarged liver
Lymph nodesNo inguinal or supraclavicular nodes
PelvicExamined by Dr. Osei-Bonsu with Ms. Perón's consent and a chaperone: a friable exophytic tumor about 4.5 cm across replacing the cervix; colposcopy of the vagina shows no spread to the vaginal walls; on rectovaginal examination the left parametrium is thickened and nodular but does not reach the pelvic wall; the right parametrium and the rectal mucosa are free
PsychiatricTearful at first, then composed; asking clear questions; no thoughts of self-harm

Problems

ProblemClinical statusVerificationCodeProvenance
Bleeding after intercourse and between periods, with heavier periods, for about four months, with tiredness and a dull pelvic ache. Never had cervical screening. Speculum examination shows a friable, exophytic mass about 4 cm across on the cervix that bleeds on contact. Punch biopsy, HPV test and cytology taken; urgent gynecologic oncology consultation bookedresolvedconfirmed N93.8S — Synthetic presenting problem linked to her documented abnormal bleeding with anemia; superseded by the diagnosis at the consultation.
Iron deficiency anemia from chronic blood loss: hemoglobin 9.4 g/dL, mean cell volume 72 fL, ferritin 6 ng/mL, with tiredness and breathlessness on stairsactiveconfirmed D50.0S — Synthetic modern finding linked to her documented anemia from vaginal bleeding.
Invasive squamous cell carcinoma of the cervix, HPV 16 positive: an exophytic tumor about 4.5 cm across with clinical involvement of the left parametrium, not reaching the pelvic wall; pelvic MRI and PET-CT ordered for FIGO 2018 staging. Synthetic modern episode linked to her documented cervical canceractiveconfirmed C53.9S — Synthetic modern diagnosis made at the gynecologic oncology consultation.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
Self-managementDisclosure and information preferences: she is told first, in Spanish, as much as she wants to know; she decides who else is toldEvery visitCompleted todayTold in person, in Spanish, alone as she asked, after checking what she wanted to know; she asked about cure, work and children, and each question was answered
ExaminationPelvic, speculum and rectovaginal examinationAt diagnosis; every three to six months for two years after treatmentCompleted todayAbout 4.5 cm tumor; left parametrial spread not reaching the pelvic wall; vagina and rectum free
ImagingPelvic MRIAt staging, for local extentOrderedWithin ten days
ImagingFDG PET-CTAt staging; about three months after chemoradiationOrderedWithin ten days, for nodes and distant spread
LaboratoryKidney function (creatinine, eGFR) and magnesium for cisplatinBefore cisplatin, weekly during it, and afterCompleted todayCreatinine 0.7 mg/dL, eGFR 117
LaboratoryHIV and hepatitis C testsAt diagnosisOrderedDrawn today with her agreement
LaboratoryBlood count (hemoglobin, white cells, platelets)About one month after starting oral iron, then every three months for a year; weekly during chemoradiationDueHemoglobin 9.4 g/dL eight days ago; next at about one month
SurveyPelvic pain score and analgesic safety (no anti-inflammatory painkillers with cisplatin)Every visitCompleted today4 of 10; acetaminophen once or twice a day
SurveyPHQ-9 and GAD-7At diagnosis, before treatment, at mid-treatment, at the end of treatment, and in follow-upCompleted todayPHQ-9 9 (item 9 scored 0), GAD-7 9, on the day of diagnosis
ReferralFertility and ovarian function counseling and her decisionBefore cancer treatment beginsCompleted todayOptions explained; her decision due at the next visit
ReferralOncology social worker and spiritual careAt diagnosis and through treatmentCompleted todaySocial worker met her today; spiritual care offered

Goal progress:

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027); Revised FIGO staging for carcinoma of the cervix uteri (2018 (published 2019)); Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline (2017); Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update (2018); Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026)

Follow-up: Results of MRI, PET-CT, HIV and hepatitis C tests at a visit in about two weeks, with Dr. Osei-Bonsu, when the stage, treatment, and her fertility decision will be discussed. Next scheduled visit 2026-03-02: staging results (pelvic MRI and PET-CT), FIGO stage, and her treatment and fertility decisions before chemoradiation. [S]